Resvila DPI Capsules – Fluticasone Furoate 100mcg + Vilanterol 25mcg
Resvila DPI Caps Is An Advanced Once-daily Dry Powder Inhaler (Dpi) Therapy Designed For The Effective Management Of Asthma And Chronic Obstructive Pulmonary Disease (Copd). This Formulation Combines Fluticasone Furoate, A Potent Anti-inflammatory Corticosteroid, With Vilanterol, A Long-acting Beta-2 Agonist (Laba), Providing Extended Relief From Respiratory Symptoms And Improving Lung Function.
Composition:
- Fluticasone Furoate 100 mcg: A highly effective corticosteroid that reduces airway inflammation and prevents exacerbations.
- Vilanterol 25 mcg: A LABA that provides sustained bronchodilation for improved breathing throughout the day.
Key Features of RESVILA DPI CAPS
- Once-Daily Dosing: Simplifies treatment regimen while providing 24-hour symptom control.
- Dual Action Relief: Combines anti-inflammatory and bronchodilating effects for comprehensive respiratory management.
- Convenient DPI Format: Ensures precise dosing and easy administration for patient compliance.
Indications:
- Maintenance treatment of asthma in patients requiring long-term control of airway inflammation and bronchoconstriction.
- Management of moderate to severe COPD, including chronic bronchitis and emphysema.
- Prevention of exacerbations in chronic respiratory diseases.
Benefits of RESVILA DPI CAPSULES
- 24-Hour Control: Provides round-the-clock relief from respiratory symptoms.
- Improved Quality of Life: Enhances breathing comfort and reduces the frequency of flare-ups.
- User-Friendly Design: Lightweight, portable, and easy to use for all age groups.
Dosage and Administration:
- 1 Capsule Once Daily via a dry powder inhaler device or as prescribed by a healthcare professional.
- Regular use is essential for optimal results; do not exceed the prescribed dosage.
Why Choose RESVILA DPI CAPS?
- An advanced, trusted solution for long-term asthma and COPD management.
- Reduces the need for frequent inhalations, ensuring better compliance.
- Scientifically proven to improve lung function and overall respiratory health.
